Seelos Therapeutics
SEEL
#10593
Rank
NZ$0.35 M
Marketcap
NZ$0.61
Share price
-31.49%
Change (1 day)
-98.20%
Change (1 year)

Earnings for Seelos Therapeutics (SEEL)

Earnings in 2024 (TTM): NZ$7.41 Million

According to Seelos Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$62.67 Million, an increase over its 2022 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seelos Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$7.41 M-111.84%
2023 -NZ$62.67 Million-48.58%
2022 -NZ$0.13 Billion14.07%
2021 -NZ$0.11 Billion240.34%
2020 -NZ$31.39 Million-62.76%
2019 -NZ$84.29 Million587.73%
2018 -NZ$12.26 Million-36.54%
2017 -NZ$19.32 Million74.83%
2016 -NZ$11.05 Million-63.26%
2015 -NZ$30.07 Million-18.06%
2014 -NZ$36.7 Million46.19%
2013 -NZ$25.1 Million-31.67%
2012 -NZ$36.74 Million
2010 -NZ$34.42 Million448.63%
2009 -NZ$6.28 Million-25.83%
2008 -NZ$8.46 Million-45.65%
2007 -NZ$15.56 Million2.82%
2006 -NZ$15.14 Million-41.86%
2005 -NZ$26.03 Million-9.27%
2004 -NZ$28.69 Million114.92%
2003 -NZ$13.35 Million-70.78%
2002 -NZ$45.69 Million60.2%
2001 -NZ$28.52 Million70.3%
2000 -NZ$16.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.25 Billion-3,626.04%๐Ÿ‡บ๐Ÿ‡ธ USA